Background. Migraine pathophysiology involves a neuronal mechanism that is closely associated with the neuronal activation of peripheral trigeminal nociceptive pathways. It also involves a vascular mechanism that is supported by studies concerning the presence of migraine with aura in various vascular diseases. Migraine is associated with silent infarctlike lesions and white matter hyperintensities (WMHs) that can be encountered during magnetic resonance imaging. In this study, we aimed to demonstrate the migraine-WMH link based on pain lateralization.
Introduction
The International Classification of Headache Disorders, 3rd edition (ICHD III), criteria define migraine as a recurrent headache disorder with attacks that last four to 72 hours with typical features that can include a unilateral location, a pulsating quality, moderate or severe intensity, aggravation by routine physical activity, and association with nausea and/or photophobia and phonophobia. The unilateral location is the first diagnostic criterion for migraine in the ICHD III classification system [1] . Migraine is responsible for 10% of unilateral headaches in the headache-suffering population [2] .
Migraine pathophysiology involves a neuronal mechanism that is closely associated with the neuronal activation of peripheral trigeminal nociceptive pathways, brainstem and diencephalic nuclei, and the cortex [3] . Migraine is also associated with silent infarct-like lesions and white matter hyperintensities (WMHs) that can be encountered during magnetic resonance imaging (MRI) assessments [4, 5] . Although imaging in migraine is often performed to exclude secondary headache causes, MRI often reveals white matter lesions in various locations [6] . Moreover, a number of MRI studies have identified an increased prevalence of WMHs in migraine patients [7] . These WMHs have been commonly interpreted as lesions of ischemic origin and are thus associated with an increased risk of ischemic stroke [8, 9] . Although association between migraine and WMHs has been sought, WMHs and laterality of the pain in migraine have not been studied up to now.
In our study, we aimed to investigate the possible relationship between hemispheric lesion accumulation and pain lateralization.
Methods
This study was approved by our institutional ethics committee, and informed consent was obtained from all subjects (or from the parents when necessary) via a questionnaire.
Participants
Between May 2014 and December 2014, all follow-up migraine patients in our center were considered in our study. In this patient population, nine-hundred and three migraine patients who had undergone brain MRI within the previous six months were contacted via voice calls or emails and were asked to respond to a questionnaire and invited to the outpatient clinic. A total of 854 patients accepted the call and met the inclusion criteria.
The inclusion criteria for the patient population were as follows: volunteered for the study, aged 15 to 45 years, established migraine diagnosis according to the ICHD-3, and had previously undergone brain MRI.
Among the selected population, 226 patients were excluded from the study according to the exclusion criteria defined below. The study ultimately consisted of 628 migraine patients.
The exclusion criteria for the selected group were as follows: any imaging finding other than focal T2 hyperintensity (N ¼ 7), a measured blood pressure greater than 120/80 mm-Hg at the time of interview (N ¼ 2), the use or presence of an antihypertensive drug (N ¼ 15), history of cardiovascular disease (N ¼ 41), any type of ongoing or recurrent headaches other than migraine (N ¼ 41), chronic migraine (whether present at the time of imaging or questionnaire; N ¼ 51), any acute or chronic disease based on the medical history (N ¼ 28), renal or thyroid dysfunction (N ¼ 18), the use of any type of medication other than migraine treatments, including oral contraceptives and antidepressants (N ¼ 41), any type of substance abuse (N ¼ 4), and a body mass index greater than 30 kg/m 2 (N ¼ 9). None of the included subjects had any neurological diseases other than migraine.
The interviews were performed by three neurologists. The neurologists were aware of the medical histories of the patients during the interviews. The first part of the questionnaire included questions about the characteristics of the migraines (i.e., disease duration, the presence of aura, and pain lateralization) and other conditions (i.e., medical history, smoking, and hyperlipidemia). A question with three options (only right-sided, only leftsided, and variable) was asked to determine the side of the pain. The second part of the questionnaire addressed the intensity of the pain (visual analog scale The patients were stratified according to smoking status and were accepted as nonsmokers if they had never smoked. Hyperlipidemia was determined according to biochemical tests that had been performed within the previous six months. A new blood sample was acquired if there were no previous tests. A serum cholesterol level of 200 mg/dL, a serum low-density lipoprotein cholesterol level of 120 mg/dL, and a serum triglyceride level of 200 mg/dL were accepted as the reference standards. If there was any elevation of one or more of the abovementioned markers, the patient was classified as hyperlipidemic.
Imaging Procedure
All MR examinations were performed with a 1, 5-T MRI scanner (Magnetom Avanto, Siemens Healthcare, Forcheim, Germany) in our center. Axial T1-weighted, axial and coronal T2-weighted, and axial and sagittal FLAIR images were acquired with a slice thickness of 4 mm and interslice gap of 0 mm. Periventricular WMHs were assessed via the use of a grading system at three different locations adjacent to the lateral ventricles. Detailed information about the technique is mentioned elsewhere [10] .
On the MR images, deep/subcortical WMHs were defined as bright foci on the T2-weighted and FLAIR images. Based on this definition, bright foci that had any dimensional diameter exceeding 1 mm in at least one of imaging planes were accepted as WMHs in this study ( Figure 1 ). All readings are performed by a single radiologist who was blind to patient data, and the number of WMHs was recorded for each participant. Headache-related and nonrelated imaging findings other than WMHs were noted, and the subjects with such findings were excluded. The following seven lesions were detected in this manner: silent infarct-like lesions (2), meningiomas (3), a tumor (1), and an extensive basal ganglia calcification (1).
The patients were divided into three subgroups, namely left-dominant, right-dominant, and codominant subgroups, based on the dominant WMH side by count. A cerebral hemisphere that contained at least 60% of the total WMH load was recorded as right-or left-dominant, whereas each hemisphere containing 40-60% of the total WMH load was recorded as codominant.
Statistical Analysis
Summary statistics are presented as the means 6 standard deviations. The normalities of the distributions were assessed with D'Agostino-Pearson tests. Group comparisons of continuous variables between more than two groups were performed with analysis of variance (normal distributions) and Kruskal-Wallis tests (non-normal distributions). Normally distributed continuous variables were compared between two groups with independent-samples t tests. Nominal categorical variables were assessed with the chi-square test. The correlations between categorical variables were assessed with Spearman rank correlations. Univariate analyses were used to associate the disease characteristics with the development of deep/subcortical WMHs. The agreement between pain lateralization and WMH dominance was assessed with kappa statistics. A two-tailed P value <0.05 was considered statistically significant. All statistical analyses were performed using MedCalc statistical software (MedCalc, version 12.2.1.0, Ostend, Belgium).
Results

Patient Demographics
Patient demographics are presented in Table 1 . Of the 628 patients, 298 (47.5%) patients had at least one deep/subcortical WMH. The mean ages of the subjects with and without deep/subcortical WMHs were 33.3 6 8.8 and 29.5 6 8.5 years, respectively. The proportions of females were 84.5% in the group of subjects with deep/subcortical WMHs and 83.6% in the group of subjects without WMHs. There were no statistically significant differences in the age groups or gender distribution (P > 0.05). The mean number of deep/subcortical WMHs per patient was 8.9 6 9.2 (range ¼ 0-64). Among the disease characteristics, age, aura, and disease duration were associated with deep/subcortical WMHs, whereas there were no associations with gender, family history, attack frequency, attack duration, VAS score, or MIDAS (Table 2) .
Among the overall study population, 362 (57.6%) patients had periventricular WMHs. The mean ages of the subjects with and without periventricular WMHs were 35.4 6 6.8 and 26.6 6 8.6 years, respectively. Among the same migraine characteristics mentioned in Table 2 , periventricular WMHs correlated only with increased age (r ¼ 0.215, P < 0.001). The proportions of females among the subjects with and without periventricular WMHs were 83.5% and 84.5%, respectively. There was no statistically significant difference between gender distributions (P > 0.05). 
Association of Pain Lateralization and WMH Dominance
We found a moderate agreement between pain lateralization and deep/subcortical WMH dominance (j ¼ 0.421, 95% CI ¼ 0.334-0.508). The data are presented in a frequency chart (Figure 2) . The association between periventricular white matter lesions and pain lateralization was not found to be statistically significant (P ¼ 0.768).
Discussion
In this study, we evaluated WMHs in patients with episodic migraine and assessed lesion accumulation by hemisphere. We found that deep/subcortical WMHs were dominantly accumulated in the cerebral hemisphere that was ipsilateral to the pain side. Furthermore, age was associated with deep/subcortical and periventricular WMHs, whereas aura was only associated with deep/subcortical WMHs.
Most WMHs are incidentally encountered during brain MRI investigations. The sensitivity and specificity are correlated with the field strength of the scanner [11] . Although smaller lesions can be detected during imaging at field strengths greater than 1.5 T, it is possible to detect WMHs with diameters greater than 1 mm at a field strength of 1.5 T [11] . The discrimination of these small lesions from normal variants, such as VirchowRobin spaces (VRS), is challenging. However, studies have demonstrated that VRS are prominent in the white matter of older patients (age > 65 years), and furthermore, only a small portion of VRS (5.5%) are located in the deep/subcortical region [12, 13] . These findings enable the evaluation of these hyperintensities and their associations with various diseases, such as migraine.
Several other studies have linked migraine with the occurrence of WMHs. In these studies, WMH development has been attributed to the migraine itself, without mention of its association with other disease characteristics Pain Side and White Matter Lesions [14] . Furthermore, some of the studies that have found an association between migraine and WMHs did not exclude possible comorbidities that could independently promote the development of WMHs [15, 16] . After accumulating sufficient data in the literature, studies began focusing on the associations between disease characteristics and WMHs. For example, disease characteristics, including aura, attack frequency, and female gender, were found to be associated with an increased risk of WMH occurrence in one study [10] , whereas similar results, with the exception of the association with female gender, were reported in another study [17] .
Longitudinal studies have also mentioned this link because migraine patients tend to have many more WMHs than participants without migraine. It has also been demonstrated that WMHs are progressive in nature. However, the effect of normal aging on WMH development should be considered in these studies [18, 19] .
Pain lateralization in migraine is not well studied. In one study, the authors found that autonomic symptoms, such as reddening of the eyes, lacrimation, rhinorrhea, and nasal congestion, are significantly more frequent in patients with unilateral migraine headaches [20] .
The pain in migraine has been suggested to be caused by the activation of the trigeminovascular system. Signals from activated nociceptors on blood vessels are transmitted to thalamic and cortical areas to produce the sensation of pain. The activation of trigeminal sensory fibers leads to neurogenic inflammation within the meningeal vasculature [21] [22] [23] . In addition to the sense of pain, a phenomenon called cortical spreading depression (CSD) has been proposed to participate in migraine with aura. In these patients, CSD is widely viewed as the electrophysiological event that underlies migraine aura [24] . In one study, the authors found that the patients who suffer from unilateral headache also have symptoms such as scotoma and visual loss, which are indicative of aura [2] .
There is an established connection between aura and deep white matter lesions. The mechanism is not clear, but it has been suggested that immediate hypoperfusion after a migraine attack is responsible [25] . In contrast, imaging studies have demonstrated that hypoperfusion occurs in the aura phase, whereas hyperperfusion occurs in the pain phase [26] . In our study, the patients tended to exhibit higher lesion counts in cerebral hemispheres that were ipsilateral to the pain side. We believe that this concordance is associated with disturbances in perfusion-both increases and decreases-in the cerebral parenchyma during the pain phase.
Considering mechanisms of both pain and WMH occurrence altogether with our study results, it is possible that pain and development of WMH in migraine might share a common mechanism, which should be the main target of treatment options. On this occasion, a clinician might be able to both treat pain and prevent lesion accumulation in the brain.
Our study also has some strengths. First, we assessed WMHs with diameters of 1 mm or greater, as exemplified in Figure 1 , whereas similar studies have assessed lesions with diameters of 3 mm. Second, we used detailed and precise inclusion-exclusion criteria to focus on patients without known risk factors for WMH development to the fullest possible extent. For this purpose, we recruited a relatively young patient population. This approach made it possible to collect data from a large number of patients without diagnoses of hypertension or chronic diseases.
Our study has some limitations. First, we did not assess infarct-like lesions in our study because the etiology of silent infarcts is complex, and when present, the numbers of these lesions are low. For this reason, it was not possible to associate these lesions with any other migraine characteristics in this study setting. Second, we did not evaluate the presence of lesions in the cerebellum because the main determinant in our study was the pain side, which is not associated with cerebellar lateralization.
Conclusion
Migraine is a complex headache disorder that is associated with WMH occurrence. The agreement between pain lateralization and lesion dominance suggests that pain in episodic migraine is associated with deep/subcortical WMH occurrence in the cerebral hemispheres.
